menu
    • menu

    Company profile for CombiGene

    NEW Drugs in Dev.: 1
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration w...
    CombiGene’s business concept is to develop effective gene therapies for treatment of difficult-to-treat diseases for which adequate treatment methods are currently lacking. The company intends to take its candidate drugs through the phases of preclinical development and initial clinical studies under its own management, and subsequently continue development and commercialization under its own management or in collaboration with other partners. Founded on the basis of scientific discoveries made at Lund University and the University of Copenhagen, CombiGene has offices at Medicon Village in Lund, Sweden.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    CombiGeneSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Medicon Village, SE-223-81 Lund
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://combigene.com/wp-content/uploads/2021/11/EN.jpg
    Linkedin
    Linkedin
    https://www.linkedin.com/company/combigene/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/combigene

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    CombiGene selects AmbioPharm as peptide CDMO partner for their COZY01 pain project
    CombiGene selects AmbioPharm as peptide CDMO partner for their COZY01 pain project

    15 Sep 2023

    // PRESS RELEASE

    https://www.ambiopharm.com/news-press/combigene-selects-ambiopharm-as-peptide-cdmo-partner-for-their-cozy01-pain-project/

    PRESS RELEASE
    15 Sep 2023
    Share Share
    Roche's Spark adds epilepsy asset to pipeline with $328M deal
    Roche's Spark adds epilepsy asset to pipeline with $328M deal

    13 Oct 2021

    // A. Armstrong FIERCEBIOTECH

    https://www.fiercebiotech.com/biotech/roche-s-spark-adds-epilepsy-asset-to-pipeline-328m-combigene-licensing-deal

    A. Armstrong FIERCEBIOTECH
    13 Oct 2021
    Share Share
    Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug
    Cobra Biologics, CombiGene Ready to Start GMP Production of Epilepsy Drug

    25 Jun 2021

    // CONTRACTPHARMA

    https://www.contractpharma.com/contents/view_breaking-news/2021-06-25/cobra-biologics-combigene-ready-to-start-gmp-production-of-epilepsy-drug-candidate/?widget=listSection

    CONTRACTPHARMA
    25 Jun 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search